BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI)
CUSIP: 09075P105
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock, par value $0.001
- Shares outstanding
- 26,011,000
- Total 13F shares
- 12,791,796
- Share change
- -245,676
- Total reported value
- $388,253,110
- Put/Call ratio
- 100%
- Price per share
- $30.35
- Number of holders
- 103
- Value change
- -$6,408,094
- Number of buys
- 61
- Number of sells
- 41
Quarterly Holders Quick Answers
What is CUSIP 09075P105?
CUSIP 09075P105 identifies BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09075P105:
Top shareholders of BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BioXcel Holdings, Inc. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 25 Jun 2021 | |
| BioXcel LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 25 Jun 2021 | |
| FMR LLC |
13F
|
Company |
12%
|
3,114,813
|
$90,516,000 | — | 30 Jun 2021 | |
| STATE STREET CORP |
13F
|
Company |
5.6%
|
1,459,115
|
$42,402,000 | — | 30 Jun 2021 | |
| Artemis Investment Management LLP |
13F
|
Company |
4.6%
|
1,193,290
|
$34,664,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.4%
|
1,132,402
|
$32,907,000 | — | 30 Jun 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
3.6%
|
943,260
|
$27,411,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.5%
|
902,646
|
$26,231,000 | — | 30 Jun 2021 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
1.1%
|
287,752
|
$8,362,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
276,819
|
$8,044,000 | — | 30 Jun 2021 | |
| Altshuler Shaham Ltd |
13F
|
Company |
1.1%
|
274,056
|
$7,964,000 | — | 30 Jun 2021 | |
| CAAS CAPITAL MANAGEMENT LP |
13F
|
Company |
0.89%
|
232,285
|
$6,750,000 | — | 30 Jun 2021 | |
| Ghisallo Capital Management LLC |
13F
|
Company |
0.87%
|
225,000
|
$6,539,000 | — | 30 Jun 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.83%
|
214,596
|
$6,236,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.69%
|
180,770
|
$5,254,000 | — | 30 Jun 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.68%
|
177,590
|
$5,160,000 | — | 30 Jun 2021 | |
| UBS Group AG |
13F
|
Company |
0.62%
|
160,603
|
$4,667,000 | — | 30 Jun 2021 | |
| LUMINUS MANAGEMENT LLC |
13F
|
Company |
0.6%
|
157,099
|
$4,565,000 | — | 30 Jun 2021 | |
| Blackstone Inc. |
13F
|
Company |
0.58%
|
150,000
|
$4,359,000 | — | 30 Jun 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.5%
|
130,957
|
$3,806,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.46%
|
119,260
|
$3,466,000 | — | 30 Jun 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.4%
|
104,413
|
$3,034,000 | — | 30 Jun 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.4%
|
102,744
|
$2,986,000 | — | 30 Jun 2021 | |
| Laurion Capital Management LP |
13F
|
Company |
0.38%
|
100,000
|
$2,906,000 | — | 30 Jun 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.31%
|
79,671
|
$2,315,000 | — | 30 Jun 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.3%
|
78,890
|
$2,292,000 | — | 30 Jun 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.26%
|
68,900
|
$2,002,000 | — | 30 Jun 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.25%
|
65,200
|
$1,895,000 | — | 30 Jun 2021 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.23%
|
60,000
|
$1,744,000 | — | 30 Jun 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.21%
|
55,802
|
$1,622,000 | — | 30 Jun 2021 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.2%
|
53,138
|
$1,544,000 | — | 30 Jun 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.19%
|
49,669
|
$1,443,000 | — | 30 Jun 2021 | |
| Swiss National Bank |
13F
|
Company |
0.16%
|
42,400
|
$1,232,000 | — | 30 Jun 2021 | |
| ACT CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
42,000
|
$1,221,000 | — | 30 Jun 2021 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.16%
|
40,532
|
$1,178,000 | — | 30 Jun 2021 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.15%
|
40,000
|
$1,162,000 | — | 30 Jun 2021 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.15%
|
40,000
|
$1,162,000 | — | 30 Jun 2021 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.12%
|
32,438
|
$943,000 | — | 30 Jun 2021 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.12%
|
31,351
|
$911,000 | — | 30 Jun 2021 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.11%
|
28,380
|
$825,000 | — | 30 Jun 2021 | |
| AlphaCentric Advisors LLC |
13F
|
Company |
0.1%
|
25,000
|
$727,000 | — | 30 Jun 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.09%
|
24,224
|
$704,000 | — | 30 Jun 2021 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.08%
|
21,270
|
$618,000 | — | 30 Jun 2021 | |
| CSS LLC/IL |
13F
|
Company |
0.08%
|
21,196
|
$616,000 | — | 30 Jun 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.08%
|
21,071
|
$612,000 | — | 30 Jun 2021 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.08%
|
20,608
|
$598,869 | — | 30 Jun 2021 | |
| Knoll Capital Management, LLC |
13F
|
Company |
0.08%
|
20,000
|
$581,000 | — | 30 Jun 2021 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.08%
|
19,700
|
$572,000 | — | 30 Jun 2021 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.07%
|
17,849
|
$518,692 | — | 30 Jun 2021 | |
| Capital Investment Advisory Services, LLC |
13F
|
Company |
0.06%
|
16,425
|
$477,000 | — | 30 Jun 2021 |
Institutional Holders of BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI) as of Q3 2021
As of 30 Sep 2021,
BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI) was held by
103 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,791,796 shares.
The largest 10 holders included
FMR LLC, Artemis Investment Management LLP, STATE STREET CORP, BlackRock Inc., ALLIANCEBERNSTEIN L.P., VANGUARD GROUP INC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and UBS Group AG.
This page lists
103
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
108
Q3 2021 holders
103
Holder diff
-5
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.